Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

13. SLE & ANCA Scouting Reports

13. SLE & ANCA Scouting Reports

FromRheumMadness Podcast


13. SLE & ANCA Scouting Reports

FromRheumMadness Podcast

ratings:
Length:
27 minutes
Released:
Mar 19, 2021
Format:
Podcast episode

Description

In this episode, the fantastic Dr. Lisa Criscione-Schreiber (crucial mentor for the RheumMadness team) reads out the scouting reports for the SLE & ANCA regions of the tournament.   Feel free to skip this episode if you've already read the reports.  Find the reports and learn more about RheumMadness here: https://sites.duke.edu/rheummadness/Scouting reports included in this episode:Belimumab for Lupus Nephritis, written by the Duke University School of Medicine Adult Rheumatology Fellowship Program; Aki Udupa, Ryan Anderson, Isaac Smith, Poorva Apte, Megan Milne, Catherine Sims, Lisa Criscione-Schreiber, and David LeverenzAnifrolumab for SLE, written by the Medical University of South Carolina Adult Rheumatology Fellowship Program; Sarah Compton, Sam Minkin, Whitney Elg-Salsman, Ana Tucker, and Jen SchmidtPEXIVAS for ANCA vasculitis, written by the Medical College of Wisconsin Adult Rheumatology Fellowship ProgramAvacpoan for ANCA vasculitis, written by the Northwestern University Adult Rheumatology Fellowship Program; Kaitlin Lima, Michael Lopker, Yoon Qiu, Julia SunIntro and Outro music:Cheery Monday by Kevin MacLeodLink: https://incompetech.filmmusic.io/song/3495-cheery-mondayLicense: http://creativecommons.org/licenses/by/4.0/
Released:
Mar 19, 2021
Format:
Podcast episode

Titles in the series (32)

The RheumMadness podcast is part of a rheumatology learning initiative sponsored by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award. Dr. Leverenz has also received grant funding from Pfizer for quality improvement work unrelated to RheumMadness.